{"filing":{"accession_number":"0001193125-26-390989","cik":"0001859795","ticker":"NVNXF","company_name":"NOVONIX Ltd","form":"6-K","filing_date":"2026-09-14","report_date":"2026-09-15","primary_document":"nvx-6k-sept-2026-09-15-a.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1859795/000119312526390989/nvx-6k-sept-2026-09-15-a.htm"},"events":[{"id":33407,"run_id":30715,"accession_number":"0001193125-26-390989","anchor_item_number":"EX-99.1","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"This exhibit is an ASX Appendix 2A application for quotation of 68,107 ordinary shares issued on vesting of employee performance rights (101,573 performance rights converted). While the immediate issuance is modest in absolute terms, the filing discloses substantial unquoted convertible securities outstanding (45.2M convertible notes, 35M convertible debentures, 21.2M performance rights, 14M options), indicating material dilution potential. The conversion of equity-linked instruments and the disclosure of the capital structure would affect a reasonable investor's assessment of dilution risk.","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-09-14","form":"6-K","submitted_at":null,"items":[{"id":36854,"accession_number":"0001193125-26-390989","item_number":"EX-99.1","item_title":"nvx-ex99_1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This exhibit is an ASX Appendix 2A application for quotation of 68,107 ordinary shares issued on vesting of employee performance rights (101,573 performance rights converted). While the immediate issuance is modest in absolute terms, the filing discloses substantial unquoted convertible securities outstanding (45.2M convertible notes, 35M convertible debentures, 21.2M performance rights, 14M options), indicating material dilution potential. The conversion of equity-linked instruments and the disclosure of the capital structure would affect a reasonable investor's assessment of dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-15T10:05:57.054316+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36854,"accession_number":"0001193125-26-390989","item_number":"EX-99.1","item_title":"nvx-ex99_1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This exhibit is an ASX Appendix 2A application for quotation of 68,107 ordinary shares issued on vesting of employee performance rights (101,573 performance rights converted). While the immediate issuance is modest in absolute terms, the filing discloses substantial unquoted convertible securities outstanding (45.2M convertible notes, 35M convertible debentures, 21.2M performance rights, 14M options), indicating material dilution potential. The conversion of equity-linked instruments and the disclosure of the capital structure would affect a reasonable investor's assessment of dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-15T10:05:57.054316+00:00","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-09-14"}]}